This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malik, A. K.
Right arrow Articles by Weller, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malik, A. K.
Right arrow Articles by Weller, S. K.

 Previous Article  |  Next Article 

J. Virol., 11 1996, 7859-7866, Vol 70, No. 11
Copyright © 1996, American Society for Microbiology

Use of transdominant mutants of the origin-binding protein (UL9) of herpes simplex virus type 1 to define functional domains

AK Malik and SK Weller
Department of Microbiology, University of Connecticut Health Center, Farmington 06030-3205, USA.

UL9, the origin-binding protein of herpes simplex virus type 1, contains six sequence motifs conserved in a large superfamily of RNA and DNA helicases. Single-amino-acid substitution mutations in these motifs inactivate UL9 function in vivo (R. Martinez, L. Shao, and S. K. Weller, J. Virol. 66:6735-6746, 1992). Overexpression of wild-type UL9 is inhibitory to plaque formation in a transfection assay which measures viral plaque formation by infectious herpes simplex virus type 1 DNA. Constructs containing mutations in motif I, II, or VI exhibit even stronger inhibitory effects in the same assay and thus can be considered strong transdominant inhibitors of plaque formation by the wild-type virus. The transdominant phenotype can be relieved by introducing a second mutation in the DNA-binding domain or by deleting the N-terminal 35 amino acids of the protein. The inhibitory effects of wild-type UL9 can also be partially relieved by deletion of amino acids 292 to 404. We propose that the N-terminal 35 amino acids of UL9 and residues 292 to 404 may define new functional domains of the UL9 protein.


This article has been cited by other articles:

  • Chattopadhyay, S., Weller, S. K. (2007). Direct Interaction between the N- and C-Terminal Portions of the Herpes Simplex Virus Type 1 Origin Binding Protein UL9 Implies the Formation of a Head-to-Tail Dimer. J. Virol. 81: 13659-13667 [Abstract] [Full Text]  
  • Link, M. A., Silva, L. A., Schaffer, P. A. (2007). Cathepsin B Mediates Cleavage of Herpes Simplex Virus Type 1 Origin Binding Protein (OBP) To Yield OBPC-1, and Cleavage Is Dependent upon Viral DNA Replication. J. Virol. 81: 9175-9182 [Abstract] [Full Text]  
  • Chattopadhyay, S., Weller, S. K. (2006). DNA Binding Activity of the Herpes Simplex Virus Type 1 Origin Binding Protein, UL9, Can Be Modulated by Sequences in the N Terminus: Correlation between Transdominance and DNA Binding. J. Virol. 80: 4491-4500 [Abstract] [Full Text]  
  • Schildgen, O., Graper, S., Blumel, J., Matz, B. (2005). Genome Replication and Progeny Virion Production of Herpes Simplex Virus Type 1 Mutants with Temperature-Sensitive Lesions in the Origin-Binding Protein. J. Virol. 79: 7273-7278 [Abstract] [Full Text]  
  • Trego, K. S., Zhu, Y., Parris, D. S. (2005). The herpes simplex virus type 1 DNA polymerase processivity factor, UL42, does not alter the catalytic activity of the UL9 origin-binding protein but facilitates its loading onto DNA. Nucleic Acids Res 33: 536-545 [Abstract] [Full Text]  
  • Marintcheva, B., Weller, S. K. (2003). Existence of Transdominant and Potentiating Mutants of UL9, the Herpes Simplex Virus Type 1 Origin-Binding Protein, Suggests that Levels of UL9 Protein May Be Regulated during Infection. J. Virol. 77: 9639-9651 [Abstract] [Full Text]  
  • Brandt, C. R., Kolb, A. W., Shah, D. D., Pumfery, A. M., Kintner, R. L., Jaehnig, E., Van Gompel, J. J. (2003). Multiple Determinants Contribute to the Virulence of HSV Ocular and CNS Infection and Identification of Serine 34 of the US1 Gene as an Ocular Disease Determinant. IOVS 44: 2657-2668 [Abstract] [Full Text]  
  • Marintcheva, B., Weller, S. K. (2003). Helicase Motif Ia Is Involved in Single-Strand DNA-Binding and Helicase Activities of the Herpes Simplex Virus Type 1 Origin-Binding Protein, UL9. J. Virol. 77: 2477-2488 [Abstract] [Full Text]  
  • Malik, A. K., Monahan, P. E., Allen, D. L., Chen, B.-G., Samulski, R. J., Kurachi, K. (2000). Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer. J. Virol. 74: 3555-3565 [Abstract] [Full Text]  
  • Mechanic, L. E., Hall, M. C., Matson, S. W. (1999). Escherichia coli DNA Helicase II Is Active as a Monomer. J. Biol. Chem. 274: 12488-12498 [Abstract] [Full Text]  
  • Kannouche, P, Angulo, J. (1999). Overexpression of kin17 protein disrupts nuclear morphology and inhibits the growth of mammalian cells. J. Cell Sci. 112: 3215-3224 [Abstract]  
  • Marintcheva, B., Weller, S. K. (2001). Residues within the Conserved Helicase Motifs of UL9, the Origin-binding Protein of Herpes Simplex Virus-1, Are Essential for Helicase Activity but Not for Dimerization or Origin Binding Activity. J. Biol. Chem. 276: 6605-6615 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»